Cresco Labs Files 6-K with Q1 2024 Financials
Ticker: CRLBF · Form: 6-K · Filed: May 16, 2024 · CIK: 1832928
| Field | Detail |
|---|---|
| Company | Cresco Labs Inc. (CRLBF) |
| Form Type | 6-K |
| Filed Date | May 16, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financials, reporting, quarterly-results
TL;DR
Cresco Labs dropped Q1 2024 financials via 6-K, check the news release from May 15th.
AI Summary
Cresco Labs Inc. filed a Form 6-K on May 16, 2024, reporting its unaudited condensed interim consolidated financial statements and management's discussion and analysis for the three months ended March 31, 2024. The filing also includes a news release dated May 15, 2024. Cresco Labs Inc. is incorporated in Delaware and has its principal executive offices in Chicago, IL.
Why It Matters
This filing provides investors with an update on Cresco Labs' financial performance and operational status for the first quarter of 2024, offering insights into the company's current financial health and strategic direction.
Risk Assessment
Risk Level: medium — As a cannabis company, Cresco Labs operates in a highly regulated and evolving industry, which presents inherent risks and uncertainties.
Key Players & Entities
- Cresco Labs Inc. (company) — Registrant
- 0001832928-24-000040.txt (document) — Filing identifier
- May 16, 2024 (date) — Filing date
- March 31, 2024 (date) — Reporting period end date
- May 15, 2024 (date) — News release date
- 600 W. Fulton Street, Suite 800 Chicago, IL 60661 (address) — Principal executive offices
FAQ
What specific financial information is included in the Form 6-K filing?
The Form 6-K includes the Unaudited Condensed Interim Consolidated Financial Statements and the Management Discussion and Analysis of Financial Condition and Results of Operations for the three months ended March 31, 2024 and 2023.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 16, 2024.
What is the primary business of Cresco Labs Inc. according to the filing?
Cresco Labs Inc. is classified under MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].
Does Cresco Labs file an annual report on Form 20-F or Form 40-F?
The filing indicates that Cresco Labs Inc. files an annual report on Form 40-F.
What other document is attached to this Form 6-K filing?
In addition to the financial statements and MD&A, the filing includes a News Release dated May 15, 2024.
Filing Stats: 188 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2024-05-15 20:59:00
Filing Documents
- q12024form6-k.htm (6-K) — 13KB
- q12024-financialstatements.htm (EX-99.1) — 1099KB
- q12024mda.htm (EX-99.2) — 231KB
- q12024pressrelease.htm (EX-99.3) — 185KB
- corporatestructurea.jpg (GRAPHIC) — 57KB
- 0001832928-24-000040.txt ( ) — 1606KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CRESCO LABS INC. Date May 15, 2024 By s Charles Bachtell Charles Bachtell Chief Executive Officer